Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data
NCT06533709 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 146
Last updated 2024-08-01
Summary
This project intends to conduct a multicenter retrospective study to evaluate the satisfactory reduction of advanced ovarian cancer using PET-CT images, and explore the correlation between molecular biological characteristics and clinical characteristics of ovarian cancer through high-throughput sequencing genomics combined with radiomics.
Conditions
- Ovarian Cancer
- Image
- Predation
Interventions
- DIAGNOSTIC_TEST
-
Radio-score
A score based on the LASSO regression model predicting the R0 resection of the primary debulking surgery of advanced ovarian cancer.
Sponsors & Collaborators
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
lead OTHER
Principal Investigators
-
huaiwu Lu · The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- China
Study Locations
More Related Trials
-
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 ·Status: COMPLETED ·Phase: NA
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings
NCT04504110 ·Status: UNKNOWN ·Phase: PHASE2
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089 ·Status: RECRUITING ·Phase: PHASE2
-
The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer
NCT03768479 ·Status: UNKNOWN ·Phase: NA
-
18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.
NCT05983796 ·Status: UNKNOWN ·Phase: NA
-
MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study
NCT02334371 ·Status: COMPLETED ·Phase: NA
-
68Ga-ICAM-1pep PET/CT in Cancer Patients
NCT04596670 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
NCT00946140 ·Status: COMPLETED
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
NCT05749289 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma
NCT03636607 ·Status: WITHDRAWN ·Phase: NA
-
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
NCT05056259 ·Status: UNKNOWN
-
BBPA PET/CT in Patients With Malignant Tumors
NCT05987098 ·Status: RECRUITING ·Phase: NA
-
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
NCT06956144 ·Status: RECRUITING
-
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)
NCT00959582 ·Status: COMPLETED ·Phase: PHASE1
-
PD-L1 Targeting Molecular Imaging of Solid Tumors
NCT04629326 ·Status: RECRUITING ·Phase: NA
-
Radiomics of Hepatocellular Carcinoma
NCT02757846 ·Status: UNKNOWN
-
The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer
NCT06915714 ·Status: COMPLETED
-
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
NCT05828238 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
NCT05030597 ·Status: RECRUITING
-
PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer
NCT03965481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors
NCT06774209 ·Status: RECRUITING ·Phase: NA